Navigation Links
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
Date:7/6/2010

Partnership with Vitro Molecular in histology and image analysis IHC biomarker development offers a complete companion diagnostics development service

(PRWEB) July 6, 2010 -- Flagship Biosciences LLC, a provider of digital pathology services, announced it has expanded its partnership with Vitro Molecular in Miami, Florida, to provide validated IHC companion diagnostic development capabilities. Vitro Molecular is a physician-owned, anatomic pathology specialty laboratory founded by Hadi Yaziji M.D. in 2007. Vitro provides routine and specialty anatomic pathology services to a loyal physician clientele in Florida and other States. The laboratory is well known for its excellence in histopathology, particularly IHC and other molecular tests. “Our pharmaceutical customers require a scalable histology operation with high levels of excellence and experience in immunohistochemistry,” said David Young, cofounder and president of Flagship Biosciences. “Quantitative image analysis techniques are strongly dependent on reproducible procedures in histology, and Dr. Hadi Yaziji and his team at Vitro Molecular have established themselves as leaders in high quality IHC testing. Dr. Yaziji’s strength in immunohistochemistry techniques, as demonstrated in his leadership of the Annual International Retreats on Applied Immunohistochemistry and Molecular Pathology, will be helpful to Flagship as we look to improve the reproducibility of molecular tissue-based testing.”

“We recognize the importance of whole slide analysis and computer histology pattern recognition in improving immunohistochemistry techniques. We are delighted to partner with Flagship Biosciences in working to ensure that their novel image analysis techniques utilize the best and most reproducible and scalable immunohistochemistry services,” stated Dr. Hadi Yaziji, founder and president of Vitro Molecular.

Flagship Biosciences LLC is a pathologist-owned company focused on utilizing whole slide scanning for quantitative pathology in pharmaceutical and device applications. An recent example of Flagship’s capabilities in companion diagnostics development of multiple IHC markers is their pathologists' work in the development of an epithelial-mesenchymal transition diagnostic test.

# # #

Read the full story at http://www.prweb.com/releases/2010/07/prweb4222034.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Active Innovations, Inc. Releases Version 8 of its Flagship Document Management Software Platform, infoRouter
2. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
3. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
5. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
6. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
7. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
8. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
9. BABYCENTER Partners In Promoting Safe And Healthy Pregnancies Through Text4baby
10. Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
11. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service 
(Date:3/27/2017)... ... 2017 , ... M&S Technologies, the first name in computerized ... System® 20/20. CE Certification builds upon M&S's long-standing commitment to products and software ... ISO and proven test methods used in the field of Vision Care. Smart ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research study, ... having the skills needed to execute that strategy, and the actual success of ...
(Date:3/27/2017)... ... 27, 2017 , ... According to the American Cancer Society , the ... than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, ... to avoid this latter group, tune in to Lifestyle Magazine on April ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year ... be an opportunity for area-residents to celebrate two great years while also familiarizing ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... British Columbia , March 27, 2017 ... Directors has appointed William "Bill" Dubiel as President and ... was also elected to the Board of Directors of ... as the Executive Chairman of LightIntegra. ... LightIntegra,s next President and Chief Executive Officer. We,ve selected ...
(Date:3/27/2017)... -- A new survey from the American Association ... Program (CBP) significantly reduced beneficiary choice and access to ... forces beneficiaries to switch to unfamiliar or unsuitable testing ... AADE,s survey is the latest in a continuous ... the inherent problems with the CBP. Last year, a ...
(Date:3/27/2017)... 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... that AGI-134, an immunotherapy for the treatment of multiple cancers, ... be featured at the upcoming American Association for Cancer ... to be held on April 1-5, 2017. ... An abstract ...
Breaking Medicine Technology: